Smith & Nephew expecting a Q4 underlying revenue decline of approximately -7%

Smith & Nephew plc

Smith & Nephew plc (LON:SN), the global medical technology business, has announced that it expects a fourth quarter underlying1 revenue decline of approximately -7%. Sales were impacted by increased rates of COVID-19 infection from mid-October onwards, particularly in the US and Europe where more procedures were postponed following the reintroduction of restrictions.

As in previous months, the impact was most pronounced on our Orthopaedic Reconstruction, Sports Medicine and ENT businesses, driven by lower levels of elective surgery. Our Advanced Wound Management and Trauma businesses remained more resilient.

Full year underlying revenue is expected to have declined approximately
-12%. As previously stated, the trading profit margin will be substantially down year-on-year, with negative operating leverage due to lower volumes partially offset by cost control measures.

Throughout 2020 we continued to serve customers, develop and launch new products and make acquisitions, whilst prioritising the health and wellbeing of employees.

Further detail of the trading performance, including franchise and regional sales performance, trading profit margin, and a review of our strategic progress in 2020, will be provided with Smith & Nephew’s fourth quarter and full year results, scheduled for 18 February 2021.

Share on:
Find more news, interviews, share price & company profile here for:

    BlackRock American Income Trust posts 2.5% NAV gain in May

    BlackRock American Income Trust plc reported a 2.5% NAV increase and 3.8% share price gain in May 2025. Strong performance in financials offset weaker energy positions.

    Avation reports strong trading and fleet expansion

    Avation has provided a trading update confirming continued fleet growth, strong rent collections, and improved aircraft values. All aircraft remain leased, with new deliveries scheduled through 2028 and further acquisitions under consideration.

    Versarien extends graphene licensing deal with Montana

    Versarien Plc has extended its licensing agreements with Montana Química LTDA for the use of its Polygrene™ graphene thermoplastic compounds in South America.

    Aptamer Group raises £2m to fund growth

    Aptamer Group plc has raised £2.0 million (before expenses) via a placing of new ordinary shares at 0.3p per share, representing a 21.1% discount.

    Marlowe publishes FY25 Annual Report following strategic transformation

    Marlowe has released its annual report and financial statements for the year ended 31 March 2025. The Group reports £304.5 million in continuing revenue, a £150 million special dividend, and a £75 million share buyback programme.

    Avation signs six-year lease agreement with PNG Air

    Avation has signed a new six-year lease with PNG Air for an ATR 72-600 aircraft, currently operated by Mandarin Airlines.

      Search

      Search